Vanguard Group’s Monopar Therapeutics MNPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
86,489
+31,255
| +57% | +$1.12M | ﹤0.01% | 3379 |
|
|
2025
Q1 | $2.01M | Sell |
55,234
-1,275
| -2% | -$46.4K | ﹤0.01% | 3489 |
|
|
2024
Q4 | $1.24M | Buy |
+56,509
| New | +$1.24M | ﹤0.01% | 3696 |
|
|
2024
Q3 | – | Sell |
-45,167
| Closed | -$33K | – | 4365 |
|
|
2024
Q2 | $33K | Hold |
45,167
| – | – | ﹤0.01% | 4322 |
|
|
2024
Q1 | $30.8K | Hold |
45,167
| – | – | ﹤0.01% | 4359 |
|
|
2023
Q4 | $15.4K | Sell |
45,167
-42,429
| -48% | -$14.4K | ﹤0.01% | 4462 |
|
|
2023
Q3 | $54.3K | Sell |
87,596
-11,580
| -12% | -$7.18K | ﹤0.01% | 4404 |
|
|
2023
Q2 | $84.8K | Sell |
99,176
-800
| -0.8% | -$684 | ﹤0.01% | 4405 |
|
|
2023
Q1 | $139K | Hold |
99,976
| – | – | ﹤0.01% | 4370 |
|
|
2022
Q4 | $237K | Buy |
99,976
+97
| +0.1% | +$230 | ﹤0.01% | 4277 |
|
|
2022
Q3 | $152K | Hold |
99,879
| – | – | ﹤0.01% | 4455 |
|
|
2022
Q2 | $230K | Hold |
99,879
| – | – | ﹤0.01% | 4455 |
|
|
2022
Q1 | $255K | Hold |
99,879
| – | – | ﹤0.01% | 4502 |
|
|
2021
Q4 | $321K | Hold |
99,879
| – | – | ﹤0.01% | 4498 |
|
|
2021
Q3 | $487K | Buy |
99,879
+2,417
| +2% | +$11.8K | ﹤0.01% | 4379 |
|
|
2021
Q2 | $574K | Buy |
97,462
+52,392
| +116% | +$309K | ﹤0.01% | 4248 |
|
|
2021
Q1 | $279K | Buy |
+45,070
| New | +$279K | ﹤0.01% | 4220 |
|